HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahide Arimoto Selected Research

XL765

5/2016Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.
8/2015Antitumor activity of a combination of dual PI3K/mTOR inhibitor SAR245409 and selective MEK1/2 inhibitor pimasertib in endometrial carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahide Arimoto Research Topics

Disease

24Neoplasms (Cancer)
12/2020 - 03/2003
11Endometrial Neoplasms (Endometrial Cancer)
11/2017 - 01/2007
10Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2020 - 01/2013
6Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 06/2012
4Endometriosis
12/2020 - 03/2003
4Carcinoma (Carcinomatosis)
10/2019 - 06/2012
3Cysts
12/2020 - 03/2003
3Ascites
04/2019 - 01/2016
2Neoplasm Metastasis (Metastasis)
12/2019 - 01/2014
2Infections
06/2016 - 02/2014
2Fever (Fevers)
07/2014 - 06/2012
2Hypersensitivity (Allergy)
01/2013 - 06/2012
1Pathologic Constriction (Stenosis)
02/2020
1Autoimmune Diseases (Autoimmune Disease)
10/2019
1Body Weight (Weight, Body)
04/2019
1Colonic Neoplasms (Colon Cancer)
10/2017
1Microvascular Angina (Cardiac Syndrome X)
10/2017
1Carcinogenesis
06/2017
1Vaginal Neoplasms (Cancer, Vaginal)
06/2016
1Uterine Prolapse (Vaginal Prolapse)
06/2016
1Idiopathic Interstitial Pneumonias
06/2016
1Lymphatic Metastasis
04/2016
1Endometrioid Carcinoma
04/2016
1Inflammation (Inflammations)
01/2016
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2016
1Surgical Wound Infection
09/2014
1Cicatrix (Scar)
09/2014
1Abscess
07/2014
1Abdominal Pain (Pain, Abdominal)
07/2014

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
04/2019 - 03/2003
4Biomarkers (Surrogate Marker)IBA
10/2019 - 03/2014
3Cisplatin (Platino)FDA LinkGeneric
05/2019 - 06/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 07/2015
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2014 - 01/2013
3Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 01/2007
3Carboplatin (JM8)FDA LinkGeneric
01/2013 - 01/2007
2SurvivinIBA
03/2018 - 01/2016
2LigandsIBA
03/2018 - 11/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 11/2016
2RNA (Ribonucleic Acid)IBA
06/2017 - 01/2016
2Small Interfering RNA (siRNA)IBA
11/2016 - 10/2016
2N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
05/2016 - 08/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2016 - 08/2015
2XL765IBA
05/2016 - 08/2015
2Complementary DNA (cDNA)IBA
01/2014 - 03/2003
2Docetaxel (Taxotere)FDA Link
01/2013 - 06/2012
2PlatinumIBA
01/2013 - 06/2012
1AntigensIBA
12/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2019
1Messenger RNA (mRNA)IBA
10/2019
1Interleukin-17 (Interleukin 17)IBA
10/2019
1B7-H1 AntigenIBA
10/2019
1Serum AlbuminIBA
04/2019
1Interleukin-6 (Interleukin 6)IBA
10/2018
1Progestins (Progestagens)IBA
11/2017
1Nicorandil (SG 75)IBA
10/2017
1Bevacizumab (Avastin)FDA Link
10/2017
1GSK-2816126IBA
06/2017
1Histone MethyltransferasesIBA
06/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2017
1RG7112IBA
11/2016
1Coloring Agents (Dyes)IBA
10/2016
1Annexin A5IBA
10/2016
1ResveratrolIBA
10/2016
1MicellesIBA
10/2016
1Prednisolone (Predate)FDA LinkGeneric
06/2016
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
04/2016
1ethyl monochloroacetate (EMCA)IBA
04/2016
1Apoptosis Regulatory ProteinsIBA
01/2016
1Estrogens (Estrogen)FDA Link
01/2016
1CytokinesIBA
01/2016
1lipoarabinomannan (LAM)IBA
01/2016
1Cyclin-Dependent Kinase 4IBA
11/2015
1Antineoplastic Agents (Antineoplastics)IBA
08/2015
1Sirolimus (Rapamycin)FDA Link
08/2015
1Chloroquine (Aralen)FDA LinkGeneric
06/2015
1Antimalarials (Antimalarial Agents)IBA
06/2015
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
04/2015
1Oncogene Proteins (Oncogene Protein)IBA
04/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2014
1olaparibIBA
03/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2014
1DNA (Deoxyribonucleic Acid)IBA
03/2014
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2014

Therapy/Procedure

8Therapeutics
04/2019 - 06/2012
7Hysterectomy
12/2020 - 01/2013
5Drug Therapy (Chemotherapy)
12/2019 - 06/2012
2Salpingo-oophorectomy
12/2020 - 01/2013
2Operative Surgical Procedures
02/2020 - 07/2015
2Trachelectomy
02/2020 - 07/2015
2Immunotherapy
10/2019 - 10/2014
2Radiotherapy
05/2019 - 07/2015
2Aftercare (After-Treatment)
02/2014 - 06/2012
1Cystectomy
12/2020
1Intravenous Injections
10/2016
1Pessaries
06/2016
1Lymph Node Excision (Lymph Node Dissection)
04/2016
1Adjuvant Chemotherapy
11/2015
1Uterine Myomectomy
09/2014
1Laser Therapy (Surgery, Laser)
02/2014